Exelixis (EXEL) Interest Expenses (2010 - 2026)
Exelixis' (EXEL) quarterly Interest Expenses came in at $2.0 million in Q2 2026, up 104.38% year-on-year from $958000.0 in Q2 2025, and up 5052.63% quarter-over-quarter from $38000.0 in Q1 2026.
Exelixis (EXEL) Interest Expenses (2010 - 2026) Analysis & Trends
Exelixis' Interest Expenses history runs 17 years deep, the most recent figure standing at $2.0 million for Q2 2026.
- On a quarterly basis, Interest Expenses rose 104.38% year-over-year to $2.0 million in Q2 2026; TTM through Apr 2026 was $2.0 million, a 104.38% increase from a year earlier, with the FY2026 full-year figure at $87.7 million, up 1.95% from the prior year.
- Interest Expenses improved to $2.0 million in Q2 2026 per EXEL's latest filing, from $38000.0 in the prior quarter.
- Across five years, Interest Expenses topped out at $86.0 million in Q1 2025 and bottomed at $38000.0 in Q1 2026.
- The 5-year median for Interest Expenses is $8.5 million (2022), against an average of $16.8 million.
- Across the five-year window, Interest Expenses jumped 17481.1% in 2022 and slumped 99.96% in 2026, its largest moves.
- Year by year, Interest Expenses stood at $77.2 million in 2022, then tumbled by 86.11% to $10.7 million in 2023, then tumbled by 89.29% to $1.1 million in 2024, then tumbled by 93.3% to $77000.0 in 2025, then soared by 2442.86% to $2.0 million in 2026.
- Per Business Quant, the three latest EXEL Interest Expenses figures stand at $2.0 million (Q2 2026), $38000.0 (Q1 2026), and $77000.0 (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -42,141.15 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 32.89 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 16.81 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 420.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 28.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 1.17 Bn |
| 10 | Exelixis | 14.38 Bn | 13.60 Bn | 590.86 Mn | 1.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 1.96 Mn |
| Apr 3, 2026 | 1.96 Mn |
| Jan 2, 2026 | 38,000.00 |
| Jan 2, 2026 | 38,000.00 |
| Oct 3, 2025 | 77,000.00 |
| Oct 3, 2025 | 77,000.00 |
| Jul 4, 2025 | 681,000.00 |
| Jul 4, 2025 | 681,000.00 |
| Apr 4, 2025 | 958,000.00 |
| Apr 4, 2025 | 958,000.00 |
| Jan 3, 2025 | 86.00 Mn |
| Jan 3, 2025 | 86.00 Mn |
| Sep 27, 2024 | 1.15 Mn |
| Sep 27, 2024 | 1.15 Mn |
| Jun 28, 2024 | 6.68 Mn |
| Jun 28, 2024 | 6.68 Mn |
| Mar 29, 2024 | 7.12 Mn |
| Mar 29, 2024 | 7.12 Mn |
| Dec 29, 2023 | 10.73 Mn |
| Dec 29, 2023 | 10.73 Mn |